Clinical Trial Update: Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 study of pegylated interferon alpha-2b in early primary myelofibrosis; the trial was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Myelofibrosis | Phase 2 | Status: TERMINATED | Results posted: 2018-07-24